/Investor DB

Almanac Insights — 2021 Investments

5 investments dated 2021 · listed companies and verified rows first · show all

Apeel Sciencesapeel.comin𝕏Aug 2021 · $250M

Apeel Sciences develops plant-based coatings derived from fatty acids and glycerides—ingredients naturally found in plant peels and seeds—that are applied to fresh fruits and vegetables to extend shelf life, preserve flavor and nutrients, and reduce reliance on refrigeration, pesticides, waxes, and plastics.

AgTechCircular EconomyCleantechClimate TechFoodTech

LouJames Rogers(Founder)inJenny Du(Founder)in

Co-investors3cubed VenturesA-Rod CorpAgFunderAndreessen HorowitzATEL VenturesBild Alternative Investments Corporation+21 more

Foxtrotfoxtrot.ioin𝕏Series B · Feb 2021 · $42M

Foxtrot provides digitization and automation software for enterprise fleets, helping them serve business and consumer clients in real-time across beverage, food, and e-commerce sectors.

Logistics & Supply ChainMobility & TransportationSaaS

Patrick Coughranin

Co-investorsRanch VenturesAlmanacBeliadeFifth WallImaginary Venture CapitalLerer Hippeau+1 more

Smallholdsmallhold.comin𝕏Series A · Nov 2021 · $25M

Smallhold grows and distributes gourmet mushrooms through a network of local farms, positioning itself as a sustainable alternative to long-distance agricultural supply chains.

AgTechClimate TechFoodTechBrooklyn, US

Andrew Carter(Executive Officer)in

Co-investorsEnergy Impact PartnersMisfit Venture PartnersSoundboard Venture FundTechstarsAlley Robotics VenturesAlleyCorp+1 more

Table 22table22.cominSeed · Apr 2021

Table22 is a platform that helps independent restaurants, food producers, and beverage retailers grow revenue through subscription and direct-to-consumer tools.

B2B MarketplacesE-commerceFoodTechLogistics & Supply ChainSaaS

Sam Bernstein(Founder)in

Co-investorsFootworkLightspeed Venture PartnersForerunner VenturesAvenir Growth CapitalFJ LabsGaingels+8 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Ark Biotech

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.